AI commercial workspace

Win more
biopharma deals.

The AI-native workspace for life sciences commercial teams to help you navigate the market and win.

miraei workspace
Business developmentCompetitive intelligenceMarketingMarket sizing
My Abstracts
Oncology Congress · 37 owned
Tied to accounts you own. Triage, then move to outreach.
Engage nowTelisotuzumab adizutecan, post-adjuvant CRCAAbbVie
Engage nowCirculating tumor DNA (ctDNA) clearanceAAmgen
Engage nowEfficacy and safety of tislelizumabBBeiGene
ReviewAssessment of ctDNA detection rateBbiomodal
ReviewLiquid biopsy to stratify metastaticBBriaCell
MRD landscape
4 indications
Where the competitive field is heating up.
Colorectal · Adjuvant MRDHigh pressure
NSCLC · 1L maintenanceWatch
Breast · Early HR+Watch
Pancreatic · ResectableStable
Veritas Dx
4 abstracts
Their messaging in colorectal MRD.
3514Podium DFS readout: MRD-guided escalation in stage III CRC
4087Real-world payer coverage of the incumbent MRD assay
LBA12Analytical validation across 1,200 colorectal samples
e15522Longitudinal surveillance and recurrence lead-time data
BMS · NSCLC pipeline
Value index 3.51
TAM
38
All assets
SAM
25
Recruiting
SOM
20
Actionable
Of 20 obtainable (SOM)where they sit today
In active partnership6
In the sales funnel9
Open · unworked5
ask miraeion this view
Business development
Ask anything about this view…
Trusted by commercial teams at 5 of the largest life sciences companies
The mandate

Closing a biopharma deal comes down to four questions.

Today they're answered across disconnected tools, by siloed teams, weeks apart. miraei answers them in one place, continuously.

01+
Market sizing
How big is the opportunity?

Build TAM, SAM, and SOM for your products to feed annual account planning and forecasting.

02+
Competitive intelligence
Who else is moving on it?

Track every competitor's trials, readouts, and congress moves, with what changed and why it matters.

03+
Business development
Who do we need to meet?

Get a scored, ranked meeting list with verified contacts and outreach drafted in your voice.

04+
Marketing
How do we win the room?

Generate battlecards and positioning tuned to each account's clinical context and likely objections.

One source of truth

One connected picture for your whole commercial team.

Market sizing, competitive intelligence, marketing, and BD draw from one place, so scattered signal becomes coordinated action and four disconnected teams move as one.

01  Ingest
02  Learn
03  Structure
04  Act
ClinicalTrials.gov
PubMed · OpenAlex
8-K · SEC filings
LinkedIn · congress data
Press · Fierce · STAT
+ your CRM, inbox & files
miraei engine
One structured record
TrialNCT05·· · Phase 1b
BiomarkerctDNA · MRD-adjacent
IndicationColorectal cancer
ContactVerified · LinkedIn
Fit score96 / 100
Market sizing
Sized — SOM of 20 trials, mapped to FY target
Business dev
Prioritized — meet Amina Costa, draft sent
Competitive intel
Watching — Veritas threat 88, deals flagged
Marketing
Armed — battlecard built on 1 ppm

Ingest, structure, act — every function works from the same record. Outcomes train the engine.

The platform

Four functions, one workspace.

Every function works from the same structured record, so a signal one team finds is instantly actionable for the rest.

Business development · Live

Walk into every congress knowing who to meet.

Scored meeting lists, verified contacts, and outreach drafted in your voice, ranked by fit, ready before you land.

Meeting targetFit
Genmab · congressDraft ready96
Arcus Bio · ESMOIn review88
Threat feed
Competitor posted Phase 2 readout
Overlaps your colorectal program · 2h ago
New trial registered · same target
Tracked to watchlist · 1d ago
Competitive intelligence · Live

See every competitive threat as it moves.

miraei reads competitor narratives across trials, data readouts, and conference activity, and tells you what changed and why it matters.

Marketing

Walk in armed with the right message.

Battlecards and positioning generated from the live record, tuned to each account's clinical context and objections.

Battlecard · Genmab
"Our ADC shows durable response in MRD-positive disease where their combo data is thin."
DifferentiatorObjection handling
Addressable · colorectal
1L MRD+
2L
3L+
Market sizing

Size the opportunity in minutes, not quarters.

Bottom-up addressable population by indication, line, and biomarker, sourced and adjustable, not a black box.

Multiplayer by design

One deal. Every team. One thread.

Sized by analytics, worked by BD, armed by marketing, watched by CI, one opportunity, one shared thread, with full memory of every conversation.

Genmab · oncology opportunityFit 96
PS
Their combo data looks thin in MRD-positive disease — that's our opening.
Priya Shah · Competitive intelligence
ML
Nice — battlecard's drafted leading with durability. Folding your point in now.
Marcus Lee · Marketing
DC
Dana Cole · Business development
EP
Amina Costa — she championed the MRD eval internally. Warm intro's ready and outreach is drafted.
Elena Park · Business development
How it learns

One workspace that compounds, interaction over interaction.

It researches, drafts, and watches in the background, with persistent memory of your goals and your accounts. Every outcome makes the next move sharper.

1
Your team works
Triage, outreach, and congress calls run through the workspace.
2
Outcomes land
Replies, meetings booked, and deals advanced get captured.
3
Signal becomes reward
Wins and misses are scored and fed back into the model.
4
Sharper next time
Better targets, drafts, and timing, automatically.
100+
qualified meetings booked in a single congress cycle
60%
of booked meetings were net-new accounts
5
of the largest biopharmas run commercial workflows on miraei

"We walked into the congress with a ranked list and drafted outreach. It changed how the whole commercial team prepares."

VP, Commercial Strategy · Global life sciences company
Questions

How miraei is different.

Commercial teams in life sciences work in silos. BD, CI, marketing, and insights each hold a piece of the picture, and none of it connects. The result is slow response, repeated work, and judgment that lives in people's heads instead of the organization. Miraei is the unified workspace that connects those functions, grounds AI in your data and context, and captures the reasoning your team does every day so the org gets smarter over time.

Commercial teams at diagnostics and biopharma companies: business development, competitive intelligence, marketing, and insights. It earns its place when those functions need to share context and move fast against conferences, competitors, and live deals.

Those are data sources or one-off deliverables. They hand you inputs, then stop. Miraei is the workspace that sits on top: it pulls those signals in, connects them to your accounts and pipeline, and turns them into decisions and actions your team can take. Data providers feed the system. They are not the system.

Frontier models are powerful but stateless and ungrounded. They don't know your accounts, retain your team's judgment, or connect to your data with provenance, so they brainstorm but can't act. Miraei grounds the model in your context, captures the reasoning your team does every day, and wires it into your workflows so the output becomes action: qualified leads, updated records, briefs a rep can walk into a meeting with. You get a system that compounds, not a blank chat box you re-explain every time.

Yes. Miraei connects to email and reads from Salesforce today, so your team's context and pipeline flow into the workspace. Writing qualified leads back into Salesforce is on the near-term roadmap.

A mix of public sources, licensed third-party providers, and your own connected systems. Everything is sourced with provenance, so any output can be traced back to where it came from.

Every output is grounded in real sources and cited. You can trace any claim back to its origin and verify before you act. We build to the life sciences bar: no unsourced assertions, no invented names or numbers walking into a customer meeting.

Your data stays yours. Each customer's data is isolated, access is tightly controlled, and SOC 2 compliance is in progress.

No. Your data is never used to train models shared with other customers. Your context, your judgment, and your records stay inside your own workspace.

Start with a focused pilot. Pick a conference, a competitor, or a set of accounts, and we stand up your workspace in days. You see value on a real use case before any broad rollout.

Request a demo

Find the right biopharma opportunities first.

Schedule a 30-minute walkthrough to see the workspace running on your own congresses, accounts, and competitors, live.

Prefer email? contact@miraei.ai
Book your walkthrough30 seconds
Pick a day
Pick a time · Pacific
Enter a valid work email.

We confirm the slot by email. No spam, ever.

Request received

We'll send a calendar invite for your selected time to your email. Watch your inbox.